Identifying and definitional attributes
|Metadata item type:||Data Set Specification|
|Registration status:||Health, Superseded 07/12/2011|
|DSS type:||Data Set Specification (DSS)|
This Cancer (clinical) data set specification is not mandated for collection but is recommended as best practice if cancer clinical data are to be collected.
The Cancer (clinical) data set underpins the evaluation of cancer treatment services and this can occur at a number of levels; the individual clinician, the health care institution, at state or territory level and ultimately at a national level.
Clinicians use such data for ongoing patient management and the ability to link patient management to outcomes allows treatments or outcomes to be identified and assessed. Institutions can monitor through-put in their centres for planning and resource allocation purposes to obtain optimum return for cancer expenditure. End-points can be monitored to ensure that objectives are being met.
The principal aim of good-quality and consistent data is to provide information that can lead to improved quality and length of life for all patients by providing a systematic foundation for evidence-based medicine, informing quality assurance and improvement decisions and guiding successful planning and evaluation of cancer control activities.
Collection and usage attributes
This data set is primarily concerned with the clinical use of cancer data. It can also be used by a wider range of health and health-related establishments that create, use, or maintain records on health-care clients.
Source and reference attributes
National Cancer Control Initiative (NCCI)
|Related metadata references:|
Has been superseded by Cancer (clinical) DSS Health, Superseded 08/05/2014
Supersedes Cancer (clinical) DSS Health, Superseded 22/12/2009